NRAS and colorectal cancer: This is a cost effective method, especially when complex testing of numerous mutations is requested: for example the RAS-testing (KRAS and NRAS mutations in exon 2, 3 and 4) in colorectal cancer performed by PentaPanel produced a significant reagent cost saving of 30% over real-time PCR or pyrosequencing analysis.